[Federal Register Volume 67, Number 237 (Tuesday, December 10, 2002)]
[Notices]
[Page 75862]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-31070]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated March 27, 2002, and published in the Federal 
Register on April 10, 2002, (67 FR 17467), Boehringer Ingelheim 
Chemicals, Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of fentanyl (9801), a basic 
class of controlled substance listed in Schedule II.
    The firm plans to bulk manufacture the listed controlled substance 
for sale to its customers.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Boehringer Ingelheim Chemicals, 
Inc., to manufacture is consistent with the public interest at this 
time. DEA has investigated Boehringer Ingelheim Chemicals, Inc. to 
ensure that the company's registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 
0.100 and 0.104, the Deputy Assistant Administrator, Office of 
Diversion Control, hereby orders that the application submitted by the 
above firm for registration as a bulk manufacturer of the basic class 
of controlled substance listed above is granted.

    Dated: November 5, 2002,
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-31070 Filed 12-9-02; 8:45 am]
BILLING CODE 4410-09-M